Arbuthnot Banking Group Plc (LON:ARBB) in its recent trading statement, advised it would make a special dividend of 300p per share (cost £45m) in Q416 against our forecast 150p. Additionally,
Hardman & Co Analyst Tony Williams talks to DirectorsTalk about what has happened to share prices in the publicly quoted housing sector since 23rd June and the Brexit vote, the
Cambridge Cognition Holdings Plc (LON:COG) is a technology company that has developed a suite of computer-based cognitive assessments to improve the understanding, diagnosis and treatment of neurological and psychological diseases.
The ‘King of Cool’ As that interloper, the re-make of ‘The Magnificent Seven’ tanks at our local Odeon, we at Hardman paused to remember The King of Cool, Steve McQueen.
City of London Investment Group Plc (LON:CLIG) issued a trading statement for the first quarter of the 2017 financial year. With only a month having passed since the year end
Although Redx Pharma Plc (LON:REDX) has only been in operation since late-2010, it has already created several valuable drug candidates that are about to begin clinical development. Progress into the
Premaitha Health Plc (LON:NIPT) uses the latest advances in DNA sequencing technology for non-invasive prenatal screening tests. IONA uses complex statistical analyses to determine the likelihood that a fetus is
Collagen Solutions Plc (LON:COS) is a biomaterials company developing and manufacturing medical grade collagen components for use in medical devices, in vitro diagnostics, and regenerative medicine. The strategic plan is
Sareum Holdings Plc (LON:SAR) is a specialist small molecule drug discovery and development company with programs in oncology and inflammatory disorders. Sareum is virtual, using collaborators and contract research organisations
Scancell Holdings Plc (LON:SCLP) is a clinical stage pharmaceutical company developing two distinct flexible cancer immunotherapy platforms, each with broad applications. ImmunoBody is a DNA vaccine which stimulates high avidity
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
